MC2039A1 - Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation - Google Patents

Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation

Info

Publication number
MC2039A1
MC2039A1 MC892053A MC2053A MC2039A1 MC 2039 A1 MC2039 A1 MC 2039A1 MC 892053 A MC892053 A MC 892053A MC 2053 A MC2053 A MC 2053A MC 2039 A1 MC2039 A1 MC 2039A1
Authority
MC
Monaco
Prior art keywords
immuno
reactive
protein
preparation
surface antigen
Prior art date
Application number
MC892053A
Other languages
English (en)
Inventor
Altenburger Werner
Binger Mary-Helen
Anthony Chizzonite Richard
Allen Kramer Richard
Thomas Lomedico Peter
J Mcandrew Stephen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2039A1 publication Critical patent/MC2039A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MC892053A 1988-06-03 1989-06-02 Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation MC2039A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20272188A 1988-06-03 1988-06-03

Publications (1)

Publication Number Publication Date
MC2039A1 true MC2039A1 (fr) 1990-05-30

Family

ID=22750986

Family Applications (1)

Application Number Title Priority Date Filing Date
MC892053A MC2039A1 (fr) 1988-06-03 1989-06-02 Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation

Country Status (22)

Country Link
US (2) US5661015A (fr)
EP (1) EP0344808B1 (fr)
JP (1) JP3051130B2 (fr)
KR (1) KR0156545B1 (fr)
CN (3) CN1040126C (fr)
AR (1) AR241942A1 (fr)
AT (1) ATE120489T1 (fr)
AU (1) AU635704B2 (fr)
CA (1) CA1340538C (fr)
DE (1) DE68921923T2 (fr)
DK (1) DK272889A (fr)
ES (1) ES2070866T3 (fr)
FI (1) FI101453B (fr)
HU (1) HU212505B (fr)
IE (1) IE67544B1 (fr)
IL (1) IL90489A0 (fr)
MC (1) MC2039A1 (fr)
NO (1) NO303876B1 (fr)
NZ (1) NZ229377A (fr)
PT (1) PT90727B (fr)
YU (1) YU47880B (fr)
ZA (1) ZA893740B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174993A (en) * 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5279960A (en) * 1984-07-05 1994-01-18 Enzon Corp. 25 KD coccidial antigen of eimeria tenella
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
US5824656A (en) * 1988-01-15 1998-10-20 Merck & Co., Inc. Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines
DE68927350T2 (de) * 1988-07-05 1997-04-24 British Tech Group Usa Gentechnologisch hergestellter coccidiose-impfstoff
ZA902147B (en) * 1989-03-28 1990-12-28 Akzo Nv Coccidiosis vaccine
EP0403698B1 (fr) * 1989-06-21 1993-09-08 Akzo Nobel N.V. Vaccin contre Eimeria tenella
ZA9010461B (en) * 1990-01-26 1991-10-30 Hoffmann La Roche Recombinant coccidiosis vaccines-5-7 eimeria surface antigen
JPH07500483A (ja) * 1991-03-14 1995-01-19 ブリティッシュ・テクノロジー・グループ・ユーエスエイ・インコーポレーテッド 組換え体抗コクシジアワクチン
US6008342A (en) * 1991-07-12 1999-12-28 Roche Vitamins Inc. DNA encoding eimeria antigen
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines
PT831897E (pt) 1995-06-07 2001-07-31 Pfizer Vacinacao in ovo contra a coccidiose
WO1996040233A1 (fr) 1995-06-07 1996-12-19 Pfizer Inc. Vaccination in ovo contre la coccidiose
ZA965586B (en) * 1995-07-03 1997-01-31 Akzo Nobel Nv Coccidiosis poultry vaccine
WO1997036613A1 (fr) * 1996-03-29 1997-10-09 Life Technologies, Inc. Procede pour augmenter la viabilite et l'efficacite de transformation de bacteries pendant leur conservation a des temperatures basses
US6632923B1 (en) 1996-11-27 2003-10-14 Boston Heart Foundation, Inc. Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
WO2003020917A1 (fr) 2001-08-30 2003-03-13 Embrex, Inc. Procedes de production d'ovocytes ameliores
KR100490669B1 (ko) * 2001-08-30 2005-05-19 (주)아비코아생명공학연구소 조류 콕시듐증을 유발하는 에이메리아 종의 포자소체 표면항원에 대한 ｓｃＦｖ 재조합 항체
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
DE10330235A1 (de) * 2003-07-04 2005-01-20 Bayer Healthcare Ag Neues Eimeria Gen und Protein sowie deren Verwendung
WO2005023866A2 (fr) * 2003-09-10 2005-03-17 Baxter International Inc. Peptides permettant d'inhiber l'activation du complement
EP1742656B1 (fr) * 2004-03-12 2010-06-16 University Of Georgia Research Foundation, Inc. Nouvel extrait de peau de cacahuète utilisé comme adjuvant de vaccin
US7087425B2 (en) * 2004-03-31 2006-08-08 Embrex, Inc. Method of purifying oocysts using enzymatic digestion of fecal debris
US20110078828A1 (en) * 2004-09-10 2011-03-31 Guardian Biotechnologies Inc. Multi epitope vaccine for poultry
EP1666489B1 (fr) * 2004-12-01 2007-11-21 Zeon Corporation ADN codant pour une protéine antigénique de eimeria apical membrane antigène 1 et utilisations de ceux-ci
CN100398156C (zh) * 2005-11-23 2008-07-02 南京农业大学 用于预防鸡球虫病的免疫调节型dna疫苗
US20080194006A1 (en) * 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
US11701683B2 (en) 2010-12-22 2023-07-18 The Procter & Gamble Company Methods for foil stamping parts having asymmetrical edges
BR112019012858A2 (pt) 2016-12-22 2019-12-10 Intervet Int Bv composição compreendendo oocistos vivos de eimeria, método para a preparação e uso da mesma, vacina para aves, método para a liberação de um agonista de tlr3 e uso do mesmo
JP2022535747A (ja) * 2019-05-28 2022-08-10 ケース ウエスタン リザーブ ユニバーシティ Ｄｎａのメチル化を保存するための組成物および方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
DE2814039C3 (de) 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
EP0135712A3 (fr) * 1983-08-19 1987-05-27 American Cyanamid Company Antigènes et anticorps monoclonaux réactifs contre les sporozoites d'Eiméria Spp.
EP0135073A3 (fr) * 1983-08-19 1987-05-27 American Cyanamid Company Antigènes et anticorps monoclonaux réactifs contre les mérozoites d'Eimeria Spp.
US4650676A (en) 1983-08-19 1987-03-17 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp.
US4710377A (en) * 1983-08-19 1987-12-01 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp.
US4874705A (en) * 1985-05-16 1989-10-17 Solvay & Cie, S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
CA1340520C (fr) * 1984-06-05 1999-05-04 Karel Z. Newman Jr. Proteines antigeniques et vaccins qui en renferment; anticorps protecteurs diriges vers eux pour prevenir la coccidiose causee par eimera tenella et eimera necatrix
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4639372A (en) 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
EP0190254A4 (fr) * 1984-07-05 1987-03-09 Genex Corp Gene clone et son procede de preparation et d'utilisation.
ES2109254T3 (es) * 1985-12-03 1998-01-16 Dimminaco Ag Sa Ltd Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
EP0241139A3 (fr) * 1986-03-13 1989-04-19 Merck & Co. Inc. Vaccin anti-idiotypique contre la coccidiose
US5496550A (en) * 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
ATE145245T1 (de) * 1987-03-06 1996-11-15 Amgen Boulder Inc Polypeptide zur verwendung bei der diagnose von kokkidien-infektion und rekombinant-dns, verfahren zur herstellung derselben
EP0315073A2 (fr) * 1987-11-02 1989-05-10 Matsushita Electric Industrial Co., Ltd. Composition pour l'obtention d'images
NZ227597A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Eimeria tenella group b immunogens and their production
NZ227595A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Recombinant production of eimeria tenella antigens and their use
AU620366B2 (en) * 1988-02-12 1992-02-20 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated response and method of producing the same
DE3926461A1 (de) * 1989-07-15 1991-01-24 Suttner Gmbh & Co Kg Ventilpistole, insbesondere fuer ein hochdruckreinigungsgeraet

Also Published As

Publication number Publication date
ZA893740B (en) 1990-02-28
DE68921923D1 (de) 1995-05-04
EP0344808A1 (fr) 1989-12-06
FI892714A (fi) 1989-12-04
IE891812L (en) 1989-12-03
YU47880B (sh) 1996-05-20
ES2070866T3 (es) 1995-06-16
FI101453B1 (fi) 1998-06-30
JP3051130B2 (ja) 2000-06-12
CA1340538C (fr) 1999-05-11
PT90727A (pt) 1989-12-29
ATE120489T1 (de) 1995-04-15
US5661015A (en) 1997-08-26
AU3601689A (en) 1989-12-07
KR910000183A (ko) 1991-01-29
NO892251D0 (no) 1989-06-02
HU212505B (en) 1996-07-29
NO303876B1 (no) 1998-09-14
CN1038837A (zh) 1990-01-17
DK272889A (da) 1989-12-04
CN1077438C (zh) 2002-01-09
HUT52963A (en) 1990-09-28
CN1187368A (zh) 1998-07-15
DE68921923T2 (de) 1995-08-10
IE67544B1 (en) 1996-04-17
EP0344808B1 (fr) 1995-03-29
IL90489A0 (en) 1990-01-18
US20030175311A1 (en) 2003-09-18
NZ229377A (en) 1992-06-25
PT90727B (pt) 1994-11-30
KR0156545B1 (ko) 1998-11-16
CN1186695A (zh) 1998-07-08
DK272889D0 (da) 1989-06-02
FI892714A0 (fi) 1989-06-02
AR241942A1 (es) 1993-01-29
NO892251L (no) 1989-12-04
JPH037594A (ja) 1991-01-14
CN1040126C (zh) 1998-10-07
CN1076204C (zh) 2001-12-19
YU113889A (en) 1991-10-31
FI101453B (fi) 1998-06-30
AU635704B2 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
MC2039A1 (fr) Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation
EP0214282A4 (fr) Antigenes protidiques ayant des determinants dependants et independants de la conformation.
FR2579762B1 (fr) Appareil d'induction d'energie ultrasonore sans contact et de detection de discontinuites acoustiques
IT1232170B (it) Emulsione multipla, in particolare di emoglobina, e procedimento per la sua preparazione
IT1196484B (it) Vettore ad espressione e secrezione in lieviti,utile per la preparazione di proteine eterologhe
IT8622630A0 (it) Anticorpi monoclonali crossreattivi e cross-protettivi contro sierotipi di p. aeruginosa.
ES2006631A6 (es) Procedimiento para la preparacion de un antigeno peptido inmunogenico correspondiente a la proteina circumsporozoito de plasmodium vivax.
PT87688A (pt) Hybrid protein c and method for its preparation
MC1884A1 (fr) Variants de l'hirudine,leur utilisation et leur preparation
AU3529889A (en) Specific cea-family antigens, antibodies specific and their methods of use
IL108419A0 (en) Proteinaceous extract derived from eimeria maxima gametocytes and vaccines against eimeria maxima containing the same
NO180181C (no) Fremgangsmåte for fremstilling av et is-kjernedannende protein, plasmider og bakteriestammer
ES2068817T3 (es) Procedimiento inmunologico de identificacion para herbicidas.
DE68914252D1 (de) Verfahren zur Bestimmung eines Antigens.
ZA879621B (en) Method for the determination of anti-p.falciparum sporozoite antibodies in human blood
AU6257486A (en) Specific mycoplasma membrane antigen and antibody and their clinical applications
JPS56166465A (en) Method of detecting blood typing antigen in tissue piece and product obtained thereby
EP0218587A4 (fr) Anticorps monoclonaux et procede d'immunisation les utilisant.
DE68907377D1 (de) Agens und geraet zur bestimmung von antigenen oder antikoerpern.
KR870004977A (ko) 2,2'-바이-1h-이미다졸 및 그의 제조방법
IT1228463B (it) Metodo e dispositivo per l'asportazione automatica e la distribuzione di oggetti piatti accatastati.
DE3850750D1 (de) Verfahren zur Verhütung von GVHD.
IL64878A (en) Method for detection of and determination of malaria antibodies and malaria antigens in human blood
NO177596C (no) Cancerassosiert SCM-gjenkjenningsfaktor, fremstilling og anvendelse
IL83231A0 (en) Small molecular weight antigen of plasmodium falciparum,antibodies directed thereto,purification and detection of said antigen

Legal Events

Date Code Title Description
YP Annual fee paid